Thelansis

  Secondary hyperparathyroidism resulting from chronic renal failure entails the inappropriate secretion of parathyroid hormone (PTH) due to a phosphocalcic metabolic imbalance. This condition often emerges concomitantly with vitamin D deficiency and chronic kidney disease (CKD). The ramifications of secondary hyperparathyroidism can significantly impact the quality of life, precipitating complications such as bone and mineral disorders, cardiovascular issues, and calciphylaxis. Diagnostic evaluation of secondary hyperparathyroidism entails monitoring various laboratory parameters, including PTH, calcium, phosphorus, vitamin D levels, and renal function. Treatment strategies focus on correcting aberrant phosphocalcic metabolism and maintaining serum calcium and phosphorus levels within the normal range while effectively managing PTH and vitamin D levels. For cases where medical interventions fail to yield satisfactory outcomes or prove refractory, parathyroidectomy represents a v...